• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • AI Executive AssistantNEW
  • Settings
  • RSS Feeds
PublishGo to AppAI Helper
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees for your businessNEW
    Legal
    Terms of usePrivacy policyCookie policy

    Sempra Appoints Jennifer M. Kirk to Board of Directors

    6/20/24 4:15:00 PM ET
    $MDT
    $SRE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care
    Natural Gas Distribution
    Utilities
    Get the next $MDT alert in real time by email

    SAN DIEGO, June 20, 2024 /PRNewswire/ -- Sempra (NYSE:SRE) (BMV:SRE) today announced the appointment of Jennifer M. Kirk to the company's board of directors effective June 20, 2024. Kirk is currently the global controller and chief accounting officer of Medtronic plc (NYSE:MDT) and has deep executive experience in finance, accounting and capital market activities, including more than 20 years in the energy industry.

    Jennifer M. Kirk

    "Bringing new perspectives into the boardroom is a critical component of our effort to support the company's mission to build North America's premier energy infrastructure company," said Jeffrey W. Martin, Sempra chairman and CEO. "Our board of directors embody a diverse set of skills, experiences and viewpoints that help guide Sempra's corporate strategy and overall business success. Jennifer's strong accounting and finance experience, coupled with her understanding of the energy business, will be a great complement to the board as we advance our corporate strategy and oversee financial discipline, risk management and ethical practices."

    Before joining Medtronic, Kirk, 49, worked at Occidental Petroleum Corporation for more than two decades, serving in roles of increasing responsibility, including senior vice president of integration and value capture, and vice president, controller and principal accounting officer.

    Kirk serves on the board of directors of Republic Services, where she is chair of the audit committee. She holds a bachelor's degree in economics from UC Santa Barbara and a master's degree in business administration from California State University, Bakersfield.

    With the appointment of Kirk, Sempra will have 10 directors with three having been newly elected over the past five years, reflecting the company's commitment to periodic board refreshment to ensure fresh and diverse perspectives are present in the boardroom. Kirk will serve on the board's audit committee and the safety, sustainability and technology committee.

    About Sempra

    Sempra (NYSE:SRE) is a leading North American energy infrastructure company focused on delivering energy to nearly 40 million consumers. As owner of one of the largest energy networks on the continent, Sempra is electrifying and improving the energy resilience of some of the world's most significant economic markets, including California, Texas, Mexico and global energy markets. The company is recognized as a leader in sustainable business practices and for its high-performance culture focused on safety and operational excellence, as demonstrated by Sempra's inclusion in the Dow Jones Sustainability Index North America and in The Wall Street Journal's Best Managed Companies. More information about Sempra is available at sempra.com and on social media @Sempra.

     

    Sempra Logo (PRNewsfoto/Sempra)

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/sempra-appoints-jennifer-m-kirk-to-board-of-directors-302177421.html

    SOURCE Sempra

    Get the next $MDT alert in real time by email

    Crush Q3 2025 with the Best AI Executive Assistant

    Stay ahead of the competition with Tailforce.ai - your AI-powered business intelligence partner.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Tailforce.ai

    Recent Analyst Ratings for
    $MDT
    $SRE

    CompanyDatePrice TargetRatingAnalyst
    Medtronic plc.
    $MDT
    6/30/2025Underperform → Peer Perform
    Wolfe Research
    Medtronic plc.
    $MDT
    6/16/2025$110.00Outperform
    Leerink Partners
    DBA Sempra
    $SRE
    4/9/2025$93.00 → $70.00Neutral
    Citigroup
    DBA Sempra
    $SRE
    3/18/2025Buy → Hold
    Argus
    Medtronic plc.
    $MDT
    3/4/2025$92.00 → $107.00Neutral → Buy
    Citigroup
    DBA Sempra
    $SRE
    3/3/2025$96.00 → $77.00Buy → Hold
    Jefferies
    DBA Sempra
    $SRE
    2/27/2025$95.00 → $72.00Overweight → Equal Weight
    Barclays
    DBA Sempra
    $SRE
    2/26/2025$95.00 → $78.00Buy → Neutral
    UBS
    More analyst ratings

    $MDT
    $SRE
    SEC Filings

    See more
    • SEC Form 144 filed by DBA Sempra

      144 - SEMPRA (0001032208) (Subject)

      7/23/25 6:12:28 PM ET
      $SRE
      Natural Gas Distribution
      Utilities
    • SEC Form 25-NSE filed by Medtronic plc.

      25-NSE - Medtronic plc (0001613103) (Subject)

      7/2/25 1:17:58 PM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Medtronic plc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits

      8-K - Medtronic plc (0001613103) (Filer)

      6/23/25 4:17:20 PM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $MDT
    $SRE
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Medtronic upgraded by Wolfe Research

      Wolfe Research upgraded Medtronic from Underperform to Peer Perform

      6/30/25 7:56:30 AM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Leerink Partners initiated coverage on Medtronic with a new price target

      Leerink Partners initiated coverage of Medtronic with a rating of Outperform and set a new price target of $110.00

      6/16/25 7:51:25 AM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Citigroup reiterated coverage on Sempra Energy with a new price target

      Citigroup reiterated coverage of Sempra Energy with a rating of Neutral and set a new price target of $70.00 from $93.00 previously

      4/9/25 8:02:34 AM ET
      $SRE
      Natural Gas Distribution
      Utilities

    $MDT
    $SRE
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SVP, Corp Affairs & HR Larroque Alexander Lisa sold $126,080 worth of shares (1,576 units at $80.00), decreasing direct ownership by 9% to 15,600 units (SEC Form 4)

      4 - SEMPRA (0001032208) (Issuer)

      7/23/25 6:14:04 PM ET
      $SRE
      Natural Gas Distribution
      Utilities
    • New insider Wold Dyan Z. claimed ownership of 4,937 shares (SEC Form 3)

      3 - SEMPRA (0001032208) (Issuer)

      7/10/25 4:46:06 PM ET
      $SRE
      Natural Gas Distribution
      Utilities
    • New insider Winn Caroline Ann claimed ownership of 55,307 shares (SEC Form 3)

      3 - SEMPRA (0001032208) (Issuer)

      7/10/25 4:44:33 PM ET
      $SRE
      Natural Gas Distribution
      Utilities

    $MDT
    $SRE
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Director Ferrero Pablo bought $184,496 worth of shares (2,600 units at $70.96), increasing direct ownership by 20% to 15,649 units (SEC Form 4)

      4 - SEMPRA (0001032208) (Issuer)

      3/17/25 9:10:57 PM ET
      $SRE
      Natural Gas Distribution
      Utilities
    • Director Conesa Andres bought $100,156 worth of shares (1,400 units at $71.54), increasing direct ownership by 7% to 21,668 units (SEC Form 4)

      4 - SEMPRA (0001032208) (Issuer)

      3/17/25 9:10:19 PM ET
      $SRE
      Natural Gas Distribution
      Utilities
    • Director Yardley James C bought $350,024 worth of shares (5,019 units at $69.74) (SEC Form 4)

      4 - SEMPRA (0001032208) (Issuer)

      3/13/25 5:02:07 PM ET
      $SRE
      Natural Gas Distribution
      Utilities

    $MDT
    $SRE
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ONCOR TO RELEASE SECOND QUARTER 2025 RESULTS AUGUST 7

      DALLAS, July 22, 2025 /PRNewswire/ -- Oncor Electric Delivery Company LLC ("Oncor") plans to release its second quarter 2025 results on August 7, prior to Sempra's (NYSE:SRE) second quarter 2025 results conference call. Oncor's earnings release will be available on Oncor's website, oncor.com. Sempra executives will host a conference call at 12 p.m. ET on Thursday, August 7 that will include discussion of Oncor's second quarter 2025 operational and financial results. Investors, media, analysts and the public may listen to a live webcast of the conference call by registering on

      7/22/25 8:00:00 AM ET
      $SRE
      Natural Gas Distribution
      Utilities
    • Sempra to Report Second-Quarter 2025 Earnings August 7

      SAN DIEGO, July 21, 2025 /PRNewswire/ -- Sempra (NYSE:SRE) plans to release its second-quarter 2025 earnings by 8 a.m. ET on Thursday, August 7. Jeffrey W. Martin, chairman and CEO, Karen Sedgwick, executive vice president and chief financial officer and other senior leaders from across the company will host a conference call at 12 p.m. ET on Thursday, August 7. Investors, media, analysts and the public may listen to a live webcast of the conference call by registering on Sempra's Investors site, part of the company's website, and clicking on the appropriate link. An accompanying slide presentation detailing the earnings results will be published to the Investors site prior to market open on

      7/21/25 4:47:00 PM ET
      $SRE
      Natural Gas Distribution
      Utilities
    • Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy, and for type 2 diabetes

      GALWAY, Ireland, July 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in Europe to expand indications of the MiniMed™ 780G system for use by individuals aged 2 years and older, during pregnancy, as well as type 2 insulin-requiring diabetes. To gain CE Mark for this expansion of indications, published clinical data in 2–6-year-olds, pregnant women, and people living with type 2 diabetes was reviewed. This expanded indication underscores the commitment Medtronic has to advancing access to automated insulin delivery (AID) technology for broader and more diverse populations, helping to improve outcomes and

      7/21/25 8:45:00 AM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care

    $MDT
    $SRE
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13G filed by DBA Sempra

      SC 13G - SEMPRA (0001032208) (Subject)

      11/8/24 10:52:39 AM ET
      $SRE
      Natural Gas Distribution
      Utilities
    • SEC Form SC 13G/A filed by Medtronic plc. (Amendment)

      SC 13G/A - Medtronic plc (0001613103) (Subject)

      2/13/24 5:09:43 PM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • SEC Form SC 13G/A filed by DBA Sempra (Amendment)

      SC 13G/A - SEMPRA (0001032208) (Subject)

      2/13/24 4:56:00 PM ET
      $SRE
      Natural Gas Distribution
      Utilities

    $MDT
    $SRE
    Financials

    Live finance-specific insights

    See more
    • ONCOR TO RELEASE SECOND QUARTER 2025 RESULTS AUGUST 7

      DALLAS, July 22, 2025 /PRNewswire/ -- Oncor Electric Delivery Company LLC ("Oncor") plans to release its second quarter 2025 results on August 7, prior to Sempra's (NYSE:SRE) second quarter 2025 results conference call. Oncor's earnings release will be available on Oncor's website, oncor.com. Sempra executives will host a conference call at 12 p.m. ET on Thursday, August 7 that will include discussion of Oncor's second quarter 2025 operational and financial results. Investors, media, analysts and the public may listen to a live webcast of the conference call by registering on

      7/22/25 8:00:00 AM ET
      $SRE
      Natural Gas Distribution
      Utilities
    • Sempra to Report Second-Quarter 2025 Earnings August 7

      SAN DIEGO, July 21, 2025 /PRNewswire/ -- Sempra (NYSE:SRE) plans to release its second-quarter 2025 earnings by 8 a.m. ET on Thursday, August 7. Jeffrey W. Martin, chairman and CEO, Karen Sedgwick, executive vice president and chief financial officer and other senior leaders from across the company will host a conference call at 12 p.m. ET on Thursday, August 7. Investors, media, analysts and the public may listen to a live webcast of the conference call by registering on Sempra's Investors site, part of the company's website, and clicking on the appropriate link. An accompanying slide presentation detailing the earnings results will be published to the Investors site prior to market open on

      7/21/25 4:47:00 PM ET
      $SRE
      Natural Gas Distribution
      Utilities
    • Sempra Declares Common Dividend

      SAN DIEGO, May 15, 2025 /PRNewswire/ -- Sempra (NYSE:SRE) today announced that its board of directors has declared a $0.645 per share quarterly dividend on the company's common stock, which is payable July 15, 2025, to common stock shareholders of record at the close of business on June 26, 2025. About SempraSempra is a leading North American energy infrastructure company focused on delivering energy to nearly 40 million consumers. As owner of one of the largest energy networks on the continent, Sempra is electrifying and improving the energy resilience of some of the world's most significant economic markets, including California, Texas, Mexico and global energy markets. The company is reco

      5/15/25 4:01:00 PM ET
      $SRE
      Natural Gas Distribution
      Utilities

    $MDT
    $SRE
    Leadership Updates

    Live Leadership Updates

    See more
    • Medtronic announces appointment of MiniMed chief financial officer ahead of intended separation into standalone company

      GALWAY, Ireland, July 8, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation into a standalone, public company. Effective July 14, 2025, Chad will be responsible for overseeing the Finance function for Medtronic Diabetes and supporting initiatives aimed at accelerating profitable growth and delivering shareholder value as it prepares to become fully independent.  Chad brings over 25 years of financial leadership experience across healthcare, consumer, and industrial sectors. Most recently, he served as CFO at BIC (BB:PA), a pu

      7/8/25 8:45:00 AM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Medtronic Board appoints Dr. Joon Lee as a new director

      GALWAY, Ireland, June 23, 2025 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that its Board of Directors appointed Dr. Joon Lee, CEO at Emory Healthcare, Inc., to the Board as an independent director, effective June 18, 2025. Dr. Lee will serve on the Science and Technology Committee and Compensation and Talent Committee of the Board. "We are thrilled to welcome Dr. Lee, a highly respected interventional cardiologist and healthcare executive, to Medtronic's Board of Directors," said Geoff Martha, chairman and chief executive officer. "Dr. Lee brings deep expertise as a clinical researcher, academic leader, and physician executive with dec

      6/23/25 4:15:00 PM ET
      $MDT
      Biotechnology: Electromedical & Electrotherapeutic Apparatus
      Health Care
    • Kayne Anderson Energy Infrastructure Fund Announces Appointment of New Independent Directors

      HOUSTON, May 27, 2025 (GLOBE NEWSWIRE) -- Kayne Anderson Energy Infrastructure Fund, Inc. (the "Company" or "KYN") announced today the appointments of Holli C. Ladhani and Michael N. Mears as independent directors of the Company, effective immediately. Following the retirements of Anne K. Costin and Albert L. Richey earlier this year, the appointments of Ms. Ladhani and Mr. Mears return the Company's Board to eight members, seven of whom are independent. Holli C. Ladhani is an experienced executive and board director in the energy, chemicals, power, and infrastructure sectors. Ms. Ladhani most recently served as President, Chief Executive Officer, and a member of the board of directors of

      5/27/25 4:15:00 PM ET
      $DVN
      $KYN
      $PWR
      $SRE
      Oil & Gas Production
      Energy
      Finance/Investors Services
      Finance